The Motley Fool

Top brokers name 3 ASX shares to sell today

On Wednesday I looked at three ASX shares that brokers have given buy ratings to this week. Unfortunately, not all shares are in favour with them right now.

Three that have just been given sell ratings are listed below. Here’s why these brokers are bearish on them:

Coca-Cola Amatil Ltd (ASX: CCL)

According to a note out of UBS, its analysts have retained their sell rating and $7.70 price target on this beverage company’s shares following its AGM update. Although the broker was pleased to see growth in Indonesian volumes, it doesn’t believe the impact on overall earnings will be material. Furthermore, although the company reiterated its expectation for mid-single digit earnings growth in FY 2020, the broker doesn’t appear overly confident with this forecast and sees downside risk to its earnings. The Coca-Cola Amatil share price is up 2% to $9.17 this afternoon.

Mayne Pharma Group Ltd (ASX: MYX)

A note out of the Macquarie equities desk reveals that its analysts have retained their underperform rating and slashed the price target on this pharmaceutical company’s shares to 55 cents following its disappointing trading update. According to the note, the broker has cut its earnings forecasts materially for FY 2019 and FY 2020 to reflect increased competition for its key Generic Products division. The Mayne Pharma share price has rebounded from its selloff on Tuesday and is up 5% to 58 cents today.

St Barbara Ltd (ASX: SBM)

Analysts at Credit Suisse have downgraded this gold miner’s shares to an underperform rating and cut the price target on them to $2.72 after it announced plans to acquire Canada-based low-cost gold producer Atlantic Gold Corporation for A$768 million. According to the note, although the broker thinks it is a good asset, it appears to believe that St Barbara has overpaid and will require success on an exploration level to create value for shareholders. The St Barbara share price is in a trading halt whilst it seeks to raise A$490 million at A$2.89 per new share to part-fund the acquisition.

Those may be the shares rated as sells, but here are the shares that have recently been named as buys.

NEW. Five Cheap and Good Stocks to Buy in 2019…

Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.

Stock #1 is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Stock #2 is another high-growth business trading near a 52-week low all while offering a 4.7% grossed-up yield...

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.


Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Coca-Cola Amatil Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

One ASX Stock For An Estimated $US22 Billion Marijuana Market

A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

And make no mistake – it is coming. To the tune of an estimated $US22 billion.

Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.

Here’s the best part: we think there’s one ASX stock that’s uniquely positioned to profit immensely from this explosive new industry… taking savvy investors along for what could be one heck of a ride.

AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.

Simply click below to learn more on how you can profit from the coming cannabis boom.

Click here to find out more